Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quick Listen: Scrip’s Five Must-Know Things

Executive Summary

In this week's podcast episode of Five Must-Know Things, hear about issues surrounding the proposed IP waiver for coronavirus vaccines, a trial delay for Novavax’s COVID-19 vaccine, an ICER review of multiple myeloma drugs and Galapagos’ efforts to refocus its R&D pipeline.

Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip's global team, in this podcast version of Five Must-Know Things.

This episode covers insights for the business week ended 14 May 2021, including: issues surrounding the proposed IP waiver for coronavirus vaccines; a trial delay for Novavax, Inc.’s COVID-19 vaccine; an ICER review of multiple myeloma drugs; and Galapagos NV’s efforts to refocus its R&D pipeline.

These and all other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Stories mentioned in this episode:

(Also see "Speed Bumps Ahead For IP Waiver But Will It Nudge Voluntary Licensing?" - Scrip, 12 May, 2021.)

(Also see "India’s COVID-19 Nightmare And How Pharma Is Holding Up" - Scrip, 6 May, 2021.) Starts at 2:43

(Also see "After Another Covid Vaccine Delay, Novavax’s Opportunity Is Shrinking" - Scrip, 11 May, 2021.) Starts at 4:25

(Also see "BCMA Drug Prices For Multiple Myeloma Don't Match Their Benefit, ICER Concludes" - Scrip, 12 May, 2021.) Starts at 6:19

(Also see "Galapagos Puts Faith In Refocused Pipeline To Regain Investor Confidence" - Scrip, 11 May, 2021.) Starts at 8:21

 

Related Content

Related Companies

UsernamePublicRestriction

Register

SC144369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel